Cited by 750Cardiac pacing and defibrillation studiesCardiac Arrhythmias and TreatmentsCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)

Open access

Glotzer, Taya V., Hellkamp, Anne S., Zimmerman, John, Sweeney, Michael O., Yee, Raymond, Marinchak, Roger, Cook, James, Paraschos, Alexander, Love, John, Radoslovich, Glauco, Lee, Kerry L., Lamas, Gervasio A.·2003·Circulation

DOI 10.1161/01.cir.0000057981.70380.45

Open this paper in CoChat — free account Open PDF

Abstract

Background— Some current pacing systems can automatically detect and record atrial tachyarrhythmias that may be asymptomatic. We prospectively studied a 312-patient (pt) subgroup of MOST (MOde Selection Trial), a 2010-patient, 6-year randomized trial of DDDR versus VVIR pacing in sinus node dysfunction (SND). The purpose of the study was to correlate atrial high rate events (AHREs) detected by pacemaker diagnostics with clinical outcomes. Methods and Results— Pacemakers were programmed to log an AHRE when the atrial rate was >220 bpm for 10 consecutive beats. Analysis was confined to patients with at least 1 AHRE duration exceeding 5 minutes. The 312 patients were median age 74 years, 55% female, and 60% had a history of SVT. 160 of 312 (51.3%) patients enrolled had at least 1 AHRE >5 minutes duration over median follow-up of 27 months. Cox proportional hazards analysis assessed the relationship of AHREs with clinical events, adjusting for prognostic variables and baseline covariates. The presence of any AHRE was an independent predictor of the following: total mortality (hazard ratio AHRE versus no AHRE and 95% confidence intervals=2.48 [1.25, 4.91], P =0.0092); death or nonfatal stroke (2.79 [1.51, 5.15], P =0.0011); and atrial fibrillation (5.93 [2.88, 12.2], P =0.0001). There was no significant effect of pacing mode on the presence or absence of AHREs. Conclusions— AHRE detected by pacemakers in patients with SND identify patients that are more than twice as likely to die or have a stroke, and 6 times as likely to develop atrial fibrillation as similar patients without AHRE.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000057981.70380.45

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.13.1449 · Cited by 2,643
Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090041008 · Cited by 1,108
Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction
Lamas, G. A., Lee, K. L., Sweeney, M. O., Silverman, R., León, A. R., Yee, R. K., Marinchak, R. A., Flaker, G., SCHRON, E. B., Orav, E. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013040 · Cited by 994
Self-citation
Pathophysiology and Prevention of Atrial Fibrillation
Allessie, M. A., Boyden, P. A., Camm, A. J., Kléber, A. G., Lab, M. J., Legato, M. J., Rosen, M. R., Schwartz, P. J., Spooner, P. M., Wagoner, D. R. V., et al. (2001) · Circulation · doi:10.1161/01.cir.103.5.769 · Cited by 724

Show all 28 references

Research works printed but not linked: 6

10.1161/circ.98.10.946 · DOI
10.1161/circ.101.8.878 · DOI
10.1161/circ.103.5.769 · DOI
10.1001/archinte.1994.00420130036007 · DOI
10.1161/circ.89.1.8281651 · DOI
10.1161/circ.88.3.8353866 · DOI

Sorted by citations

Items 501–600 of 749

Cryptogenic Acute Ischemic Stroke: Assessment of the Performance of a New Continuous Long-Term Monitoring System in the Detection of Atrial Fibrillation
Sampaio, R. F., Gomes, I. C., & Sternick, E. B. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180112 · Cited by 5
Optimization of Pacing Algorithms to Prevent and Treat Supraventricular Tachyarrhythmias
Ricci, R. P., Boriani, G., Grammatico, A., & Santini, M. (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00484.x · Cited by 5
Curative Ablation for Atrial Fibrillation:
Shah, D. C. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.14.s9.21.x · Cited by 5
Atrial fibrillation detection using implantable cardiac monitors: Are we being too revealing?
PASSMAN, R. S. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.08.005 · Cited by 5
The clinical role of closed loop stimulation pacemakers in the treatment of patients with sinus node dysfunction: a review
Gargaro, A., BIANCALANA, G., Botto, G. L., & Brignole, M. (2025) · Future Cardiology · doi:10.1080/14796678.2025.2507464 · Cited by 5
“It is associated with an increased risk of progression to clinical AF and major cardiovascular events [67–74].”
A cost comparison of atrial fibrillation monitoring strategies after embolic stroke of undetermined source
Chalfoun, N. T., Pierobon, J., Rosemas, S. C., Fox, J., Albano, A. J., Banno, J., Brunner, M., Corner, K., Dahu, M. I., Dandamudi, S., et al. (2022) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2022.100195 · Cited by 4
“%) of patients experienced an AF episode of 6 min or greater, which has been shown to be associated with a significant increase in the risk of stroke or systemic embolism [24,25].”
Background
Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life
Gura, M. T. (2015) · AACN Advanced Critical Care · doi:10.1097/nci.0000000000000111 · Cited by 4
Clinical, Echocardiographic, and Electrocardiographic Predictors of Persistent Atrial Fibrillation after Dual-Chamber Pacemaker Implantation: An Integrated Scoring Model Approach
Cho, M. S., Kim, J., Kim, J. H., Kim, M., Lee, J. H., Hwang, Y. M., Jo, U., Nam, G., Choi, K., & Kim, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160422 · Cited by 4
Atrial high-rate episodes predict clinical outcome in patients with cardiac resynchronization therapy
Jacobsson, J., Platonov, P. G., Reitan, C., Carlsson, J., & Borgquist, R. (2016) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2016.1260768 · Cited by 4
“death or stroke.[11,27,28] Yet, pre-specified cut-points as well as the analyzed variables differed.”
Background
Resilient Linear Classification: An Approach to Deal with Attacks on Training Data
Park, S., Weimer, J. E., & Lee, I. (2017) · ScholarlyCommons (University of Pennsylvania) · doi:10.48550/arxiv.1708.03366 · Cited by 4
Hardware design issues and functional requirements for smart wristband monitor of silent atrial fibrillation
Roj, D., Wróbel, J., Matonia, A., & Sobotnicka, E. (2017) · International Conference Mixed Design of Integrated Circuits and Systems · doi:10.23919/mixdes.2017.8005283 · Cited by 4
Pacing for Sinus Node Disease: Indications, Techniques, and Clinical Trials
Gillis, A. M. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2536-8.50018-2 · Cited by 4
Atrial pacing as a new predictor for atrial high rate episodes in patients with dual-chamber pacemaker
Devesa, A., García-Talavera, C. S., Benezet‐Mazuecos, J., Iglesias, J. A., Serrano, E., Borque, P. S., Miracle, A. L., & Campal, J. M. R. (2020) · REC CardioClinics · doi:10.1016/j.rccl.2020.07.004 · Cited by 4
Use of an Atrial Lead with Very Short Tip-To-Ring Spacing Avoids Oversensing of Far-Field R-Wave
Kolb, C., Nölker, G., Lennerz, C., Jetter, H., Semmler, V., Pürner, K., Gutleben, K., Reents, T., Lang, K., Lotze, U., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038277 · Cited by 4
Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions
Hyman, D. A., Siebert, V., Jia, X., Alam, M., Levine, G. N., Virani, S. S., & Birnbaum, Y. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-06849-7 · Cited by 6
Screening for Atrial Fibrillation and the Role of Digital Health Technologies
Richardson, E., Hall, A., & Mitchell, A. R. J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88660 · Cited by 4
Is the risk of stroke in permanent and paroxysmal atrial fibrillation really the same? Therein lies the dilemma
Genovesi-Ebert, A., Dini, C. S., Fusco, S. A. D., Imperoli, G., & Colivicchi, F. (2020) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000977 · Cited by 4
Where are we, and where are we heading in the device management of ventricular tachycardia/ventricular fibrillation?
Mehra, R., & DeGroot, P. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.09.010 · Cited by 4
Exploring the Potential Role of Catheter Ablation in Patients with Asymptomatic Atrial Fibrillation: Should We Move away from Symptom Relief?
Forleo, G. B., Biase, L. D., Rocca, D. G. D., Fassini, G. M., Santini, L., Natale, A., & Tondo, C. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.961 · Cited by 4
“Risk of stroke in asymptomatic AF Glotzer et al. 2003 (61) 312 with PMK that monitor AHRE 27 • 51.3% of cases with AHRE • hazard ratio AHRE vs. non-AHRE for death or non-fatal risk of stroke: 2.79 Glotzer et al. 2009 (62) 2486 with ≥ stroke risk factors receiving PMK or ICD that monitor AT/AF…”
BackgroundInfluential
The Relationship between Diffusion-Weighted Magnetic Resonance Imaging Lesions and 24-Hour Rhythm Holter Findings in Patients with Cryptogenic Stroke
Gürdoğan, M., Kehaya, S., Korkmaz, S., Altay, S., Özkan, U., & Kaya, Ç. (2019) · Medicina · doi:10.3390/medicina55020038 · Cited by 4
Atrial Fibrillation and Stroke
Mulpuru, S. K., Rabinstein, A. A., & Asirvatham, S. J. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2013.11.001 · Cited by 4
Atrial Tachyarrhythmias Detected by Automatic Mode Switching:
Estes, N. A. M. (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.04112.x · Cited by 4
Controversies in pacing: Indications and programming
Gillis, A. M., & Willems, R. (2005) · Current Cardiology Reports · doi:10.1007/s11886-005-0086-3 · Cited by 4
Atrial antitachycardia pacing: do we still need to talk about it?
Janko, S., & Hoffmann, E. (2009) · EP Europace · doi:10.1093/europace/eup182 · Cited by 4
Device-detected atrial tachyarrhythmias: what do we know?
Healey, J. S. (2011) · EP Europace · doi:10.1093/europace/eur325 · Cited by 4
Subclinical Atrial Fibrillation, Embolic Risk, and Anticoagulant Treatment.
Gherasim, L. (2018) · Europe PMC (PubMed Central) · doi:10.26574/maedica.2018.13.4.261 · Cited by 4
Continuing evaluation of atrial fibrillation detection after cryptogenic stroke: 2-year findings from a multicentre study with Confirm Rx ICM
Quartieri, F., Baek, Y., Park, J. S., Kim, T., Honma, K., Morimoto, M., Kang, K., Feng, L., Lee, K., Grammatico, A., et al. (2025) · Open Heart · doi:10.1136/openhrt-2025-003242 · Cited by 3
“Although all participating electrophysiol-ogists followed standardised criteria for AF diagnosis and the adjudication process was carefully documented at each site, we acknowledge that central adjudication might have provided additional standardisation.”
Self-citation
Impact of atrial fibrillation burden on quality of life and prediction of health care utilization: Primary results from the DEFINE AFib study
Piccini, J. P., Russo, A. M., Peacock, J. M., PASSMAN, R. S., Hills, M. T., Mittal, S., Hylek, E. M., Hong, M. F., McCEARLEY, S. S., Frankel, D. S., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.02.024 · Cited by 3
Effect of atrial high-rate episodes (AHREs) on functional status and quality of life (QoL) in heart failure—cardiac resynchronization therapy population
Allam, L. E., Moneim, Y. A., Eldamanhoury, H., & Eltoukhy, S. M. A. (2025) · The Egyptian Heart Journal · doi:10.1186/s43044-025-00613-7 · Cited by 3
“Previous studies have demonstrated that AHREs are strongly correlated with clinically diagnosed AF [4] and are independently linked with an increased risk of ischemic stroke and systemic embolism [5–7].”
Influential
The impact of stored atrial rhythm diagnostics in permanent pacemakers and the management of atrial fibrillation: the Vitatron Selection AFm Registry study
For the Vitatron Selection AFm Investigators, Kim, M. H., Reiter, M. J., Canby, R. C., Navone, A., Lung, T., & Pfeiffer, J. (2010) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-010-9492-6 · Cited by 3
The Role of Implantable Devices to Treat Atrial Fibrillation
Santini, L., & Santini, M. (2015) · Future Cardiology · doi:10.2217/fca.15.61 · Cited by 3
Device-Detected Atrial Fibrillation—Perils and Pitfalls
Surapaneni, P. K., Safadi, A. R., Contractor, T. A., Patel, M. B., & Thakur, R. K. (2016) · Cardiology Clinics · doi:10.1016/j.ccl.2015.12.007 · Cited by 3
Diastolic Electrocardiographic Parameters Predict Implantable Device Detected Asymptomatic Atrial Fibrillation
Tekkeşin, A. İ., Velibey, Y., Türkkan, C., Alper, A. T., Çakıllı, Y., Güvenç, T. S., Tanık, O., Kaya, A., Yıldırımtürk, Ö., Özbilgin, N., et al. (2017) · Balkan Medical Journal · doi:10.4274/balkanmedj.2016.0246 · Cited by 3
The Temporal Relationship Between Atrial Fibrillation and Ischemic Stroke.
Ziegler, P. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.738 · Cited by 3
New atrial arrhythmia occurrence in single chamber implantable cardioverter defibrillator patients: A real‐world investigation
Patel, D. R., Rao, A., Friedman, P. A., Deshmukh, A. J., Lande, J. D., Murphy, J. A., Brown, M. L., Lexcen, D. R., & Wilkoff, B. L. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15790 · Cited by 3
Tachy-brady syndrome: Electrophysiology and evolving principles of management
Padda, I., Sebastian, S. A., Khehra, N., Mahtani, A. U., Sethi, Y., Panthangi, V., Fulton, M., Bandyopadhyay, D., & Johal, G. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101637 · Cited by 3
The impact of the right heart cavities echocardiographic features on atrial-high rate episodes
Artaç, İ., Karakayalı, M., Omar, T., İliş, D., Arslan, A., Sahin, M. H., Karabağ, Y., & Rencüzoğulları, İ. (2023) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-023-02990-z · Cited by 3
Challenging anticoagulation decisions in atrial fibrillation: a narrative review
Griffin, M., Proietti, R., Lip, G. Y. H., & Abdul‐Rahim, A. H. (2024) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/17539447241290429 · Cited by 3
Rhythm Control Better Prevents Stroke than Rate Control in Patients with Concomitant Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Nationwide Population Based Cohort Study with Long-Term Follow-Up.
Wu, S., Chen, Y.-Y., Chien, Y.-S., Kuo, M., Li, C.-H., Weng, C., Lin, J., Hsiao, Y.-Y., Li, G., Lin, C., et al. (2025) · PubMed Central · doi:10.6515/acs.202501_41(1).20241111a · Cited by 3
Prognostic values of atrial high-rate episodes on mortality risks in CIED patients
Wattanachayakul, P., Yanpiset, P., Kulthamrongsri, N., Prasitsumrit, V., Lo, K. B., Kewcharoen, J., & Mainigi, S. K. (2025) · Journal of Cardiology · doi:10.1016/j.jjcc.2025.02.010 · Cited by 3
Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter-defibrillators: A propensity score-matched analysis
Malanchini, G., Celentano, E., Curnis, A., Rovaris, G., Biffi, M., Baroni, M., Caravati, F., Bontempi, L., Nicolis, D., Zanotto, G., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133323 · Cited by 3
Implantable Cardiac Rhythm and Hemodynamic Monitors
Daly, M. G., Melton, I., & Crozier, I. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37804-8.00025-0 · Cited by 3
Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation
Matos, J. D., Waks, J. W., & ZIMETBAUM, P. J. (2018) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2018.090404 · Cited by 3
Devicebasiertes Telemonitoring
Duncker, D., Michalski, R., Müller‐Leisse, J., Zormpas, C., König, T., & Veltmann, C. (2017) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-017-0521-3 · Cited by 3
“Zwar haben zahlreiche Studien gezeigt, dass AHRE bestimmter Längemit einer erhöhten Inzidenz thrombembolischer Ereignisse assoziiert sind, der Grenzwert für ein relevant erhöhtes Schlaganfallrisiko jedoch zwischen 5min [20] und 24 h [45] variiert.”
Resilient linear classification
Park, S., Weimer, J. E., & Lee, I. (2017) · ACM/IEEE International Conference on Cyber-Physical Systems (ICCPS) · doi:10.1145/3055004.3055006 · Cited by 3
Does Atrial Fibrillation Detected by Cardiac Implantable Electronic Devices Have Clinical Relevance?
Glotzer, T. V., & Ziegler, P. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2013.11.001 · Cited by 3
Self-citation
Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary
Waks, J. W., & ZIMETBAUM, P. J. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.849572 · Cited by 3
Reduction of atrial fibrillation in remotely monitored pacemaker patients: results from a Chinese multicentre registry
Chen, K., Dai, Y., Hua, W., Jie-Fu, Y. A. N. G., Li, K., Liang, Z., Shen, F., Chen, S., Su, Y., Ding, Y., et al. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20130106 · Cited by 3
WITHDRAWN: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.05.001 · Cited by 2
Dépistage et implications cliniques de la fibrillation atriale silencieuse
Guénancia, C., Garnier, F., Mouhat, B., Béjot, Y., Maillot, N., Fichot, M., Fauchier, L., & Cottin, Y. (2017) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2017.08.006 · Cited by 3
The Importance and Future of Population Screening for Atrial Fibrillation
Shin, S. Y., & Lip, G. Y. H. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.08.016 · Cited by 3
Left Atrial Appendage Occlusion in the Management of Stroke in Patients With Atrial Fibrillation
Ojo, A. O., Yandrapalli, S., Veseli, G., Karim, M., Aronow, W. S., Sharma, M., Frishman, W. H., Naidu, S. S., Jacobson, J. T., & Iwai, S. (2018) · Cardiology in Review · doi:10.1097/crd.0000000000000240 · Cited by 3
“The Atriclip is applied epicardially and the Atriclip system has a self-closing, sterile, implantable clip with a reusable miltex deployment tool.68 The Atriclip in loaded into the jaws of the deployment tool and the LAA is mobilized within the clip during open chest surgery.68 When closed, the clip applies uniform pr…”
BackgroundMethodInfluential
Antithrombotic Treatment after Atrial Fibrillation Ablation
Antoniou, C. K., Manolakou, P., Αρσένος, Π., Dilaveris, P., Gatzoulis, K. A., & Tousoulis, D. M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200407154329 · Cited by 3
Episódios de Alta Frequência Atrial e sua Associação com Eventos Isquêmicos Cerebrais em Pacientes Chagásicos
Freitas, E. L., Sampaio, E. E. S., Oliveira, M. M. C., Oliveira, L. H., Guimarães, M. S. D. S., Pinheiro, J. D. O., Magalhães, L. P., Albuquerque, G. S. B., Macedo, C., & Aras, R. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20190647 · Cited by 3
“A partir da detecção dos EAFAs com duração ≥ 6 minutos, foram definidos 4 subgrupos: (1) EAFAs entre 6 minutos e 29 minutos; (2) EAFAs entre 30 minutos e 5 horas e 59 minutos; (3) EAFAs entre 6 horas e 23 horas e 59 minutos e (4) EAFAs ≥ 24 horas.”
BackgroundInfluential
The Link Between CHA2DS2-VASc Score and Thromboembolic Risk in Patients Without Known Atrial Fibrillation: Are We Missing a Silent Culprit?
Lakkireddy, D. (2020) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2303 · Cited by 3
Use of Smartphones and Wearables for Arrhythmia Monitoring
Sanders, D. J., Wasserlauf, J., & PASSMAN, R. S. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2021.04.004 · Cited by 3
Pacemaker selection: time for a rethinking of complex pacing systems
Silberbauer, J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi803 · Cited by 3
Influence of structural heart disease on characteristics of atrial fibrillation recurrence in patients with dual-chamber pacemakers
Reiter, M. J., Harsch, M. R., Lung, T., Munneke, D., Kim, M. H., & Shalaby, A. A. (2008) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2008.09.002 · Cited by 3
The Cacophony of Silent Atrial Fibrillation
Glotzer, T. V. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.520 · Cited by 3
Self-citation
Atrial Fibrillation and Cryptogenic Thromboembolic Events
Henz, B. D., & Leite, L. R. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180141 · Cited by 4
Left Atrial Enlargement and Sick Sinus Syndrome for Pacemaker Indication Were Associated with Atrial High Rate Episodes
Jang, S.-W. (2021) · Korean Circulation Journal · doi:10.4070/kcj.2020.0515 · Cited by 3
Utility of speckle-tracking echocardiography for predicting atrial fibrillation following ischemic stroke: a systematic review and meta-analysis
Gao, Q., Liu, P., Lv, T., Yang, Y., & Zhang, P. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02570-7 · Cited by 2
Validation of Smartwatches Integrated With Photoplethysmography for Continuous Evaluation of Atrial Fibrillation Burden
Zuo, S., Zhou, L., Feng, H., Massad, C. M., Khalil, M. A., Wang, J., Wang, J., Zhao, Y., Li, F., Kong, X., et al. (2026) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2026.03.036 · Cited by 4
Atrial fibrillation detected by dual-chamber pacemakers and structural heart disease
Görenek, B., & Kudaiberdieva, G. (2009) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2009.03.003 · Cited by 2
Stroke Risk in Patients with Implanted Cardiac Devices
Houmsse, M., & Daoud, E. G. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2013.10.002 · Cited by 2
Enhanced detection of atrial tachyarrhythmias with pacing devices by using more accurate atrial sensing
Pakarinen, S., Lehto, M., RUITER, J. H., & de Voogt, W. G. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-021-01066-z · Cited by 2
Implantable loop recorders in patients with atrial fibrillation
Sharma, A. N., McIntyre, W. F., Nguyen, S. T., & Baranchuk, A. M. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2153673 · Cited by 2
Use of Anticoagulation for Thromboembolic Prophylaxis in Patients With Atrial High-Rate Episodes on Device Monitoring: A Narrative Review
Leung, A. N. W., & Bhat, A. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.11.009 · Cited by 2
Long duration of atrial high‐rate episode is more favorable in predicting ischemic stroke than high CHA2DS2‐VASc score
Ding, X., Ding, W., Chen, Y., Dai, B., Zhao, Y., Duo‐Duo, Z., Yang, Y., Gao, L., Xia, Y., & Dong, Y. (2023) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14857 · Cited by 2
Controversies in Diagnosis and Management of Atrial Fibrillation
Nayak, T., Lohrmann, G. M., & PASSMAN, R. S. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000761 · Cited by 2
An Evaluation of Neuron-Specific Enolase as a Biomarker of Neurological Impact in Pacemaker-Implanted Patients with Atrial High-Rate Episodes: An Observational Study from Turkey
Çınar, A., Gedikli, Ö., Uyanik, M., Avcı, B., & Terzi, Ö. (2025) · Medicina · doi:10.3390/medicina61020324 · Cited by 2
“Previous studies on the neurological effects of AHRE have emphasized its strong association with ischemic stroke [11–13].”
Pharmacotherapy changes following pacemaker implantation in patients with bradycardia–tachycardia syndrome
Ruciński, P., Rubaj, A., & Kutarski, A. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.16.2203 · Cited by 2
Advances in the Detection and Monitoring of Atrial Fibrillation for Patients with Cryptogenic Ischemic Stroke
Sangha, R. S., & Bernstein, R. A. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0544-3 · Cited by 2
Prevalencia de fibrilación auricular y factores predictores de su aparición en pacientes portadores de marcapasos bicamerales
Fernández, G., Maid, G. F., Arias, A., Maldonado, S., Pizarro, R., & Belziti, C. A. (2016) · Archivos de cardiología de México · doi:10.1016/j.acmx.2016.04.008 · Cited by 2
Empirical anticoagulation for patients in sinus rhythm at high risk of ischaemic stroke: A review of current literature
Battipaglia, I., O’Neill, J., Hogarth, A. J., & Tayebjee, M. H. (2017) · World Journal of Cardiology · doi:10.4330/wjc.v9.i5.422 · Cited by 2
When is Device-Detected Atrial Fibrillation Actionable?
Wasserlauf, J., & PASSMAN, R. S. (2018) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2017.11.007 · Cited by 3
What we have learned from the European Heart Rhythm Association consensus document on device-detected subclinical atrial tachyarrhythmias
Özcan, E. E. (2018) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2017.8223 · Cited by 2
“Consider no antithrombotic therapy for any patient with CHA2DS2-VASc score of 0 in males or 1 in females irrespective of AHRE.”
BackgroundInfluential
Atrial Fibrillation and the Role of Thumb ECGs
Magnusson, P., Samuelsson, M., Pergolizzi, J. V., Annabi, H. M., & LeQuang, J. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.83660 · Cited by 2
In the Wake of the AFFIRM Trial: What We Still Don't Know About the Management of Atrial Fibrillation and Where We Need to Go
Wyse, D. G. (2003) · Cardiac Electrophysiology Review · doi:10.1023/a:1027455314996 · Cited by 2
Prevalence and predictors of subclinical atrial fibrillation in hospitalized older adults
Spannella, F., Giulietti, F., Pimpini, L., Lombardi, F. E., Re, S., Schiavi, P., Dragano, G., Antonicelli, R., & Sarzani, R. (2021) · Aging · doi:10.18632/aging.203270 · Cited by 2
The efficacy of single-lead implantable cardioverter-defibrillator with atrial sensing dipole to detect atrial fibrillation and to reduce inappropriate therapy according to atrial sensing ON or OFF: Rationale and design of the SMART-CONTROL study, a prospective multicenter randomized trial
Gwag, H. B., Kim, H. R., Park, S., Kim, J., Chung, T. W., Choi, J., Kim, J. Y., Park, K., On, Y. K., & Kim, J. S. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.05.008 · Cited by 2
When to set anticoagulant therapy in asymptomatic AF? looking for a cut-off duration
Rossini, R., & Peirone, A. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac086 · Cited by 2
Progression of Device-Detected Atrial High-Rate Episodes and the Risk of All-Cause Mortality
Jiang, J., Sun, X., Cheng, C., Chen, K., Hua, W., Su, Y., Xu, W., Chen, R., & Zhang, S. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.07.013 · Cited by 2
Pacing mode selection in patients with sick sinus syndrome.
Nielsen, J. C. (2007) · PubMed · Cited by 2
Application of wireless remote electrocardiogram monitoring device in atrial fibrillation patients undergoing radiofrequency catheter ablation
Urbina, D., Lu, Y., Chou, C., Wu, C.-T., Wang, C., Yeh, Y., Chang, P., Wang, C., Wo, H.-T., & Wen, M. (2018) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2018.06.001 · Cited by 2
Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial
Yang, Y., Xu, F., Tong, J., Cai, L., Jiang, W., Sheng, X., Pan, Y., Jiang, J., Zhang, J., Jiang, D., et al. (2018) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6807-9 · Cited by 3
Second look Holter ECG in neurorehabilitation
Knecht, S., Petsch, S., Kirchhof, P. F., & Studer, B. (2019) · Neurological Research and Practice · doi:10.1186/s42466-019-0046-9 · Cited by 2
Arrhythmia Monitoring Through Pacemakers
Piot, O. (2003) · Circulation · doi:10.1161/01.cir.0000093724.86105.49 · Cited by 2
Stroke and pacing mode: is pacing mode important?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
Kerr, C. R. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.016 · Cited by 2
Stroke Stop Study: editorial comment
Glotzer, T. V. (2012) · EP Europace · doi:10.1093/europace/eus234 · Cited by 2
Self-citation
Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices: Editorial comment
Glotzer, T. V. (2021) · EP Europace · doi:10.1093/europace/euab242 · Cited by 2
Self-citation
Detection and management of subclinical atrial fibrillation in implantable and wearable devices
Berg, J., & Haegeli, L. (2021) · Cardiovascular Medicine · doi:10.4414/cvm.2021.02180 · Cited by 1
Racial Differences in Device-Detected Incident Atrial Fibrillation
Goergen, J. A., Peigh, G., Varberg, N., Ziegler, P., Roberts, A. I., Stanelle, E. J., Soderlund, D. M., Khan, S. S., & PASSMAN, R. S. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.10.006 · Cited by 1
ASSOCIATIONS OF RISK FACTORS AND OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION
Сергеевна, С. А., & Филиппов, Е. В. (2025) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2025-14-2-32-40 · Cited by 1
Long-term outcomes of atrial antitachycardia pacing to prevent progression to permanent atrial fibrillation in patients implanted with pacemakers
Nakatsuji, K., Otsuki, S., Kamakura, T., Oshima, T., Nakamura, T., Oka, S., Miyazaki, Y., Wakamiya, A., Ueda, N., Nakajima, K., et al. (2025) · Heart Rhythm O2 · doi:10.1016/j.hroo.2025.05.001 · Cited by 1
Contemporary Practices for Management of Subclinical Atrial Fibrillation
Alhwarat, B., Darwish, O., Ghanta, S. N., Rana, A., Gautam, N., Al'Aref, S., & Devabhaktuni, S. R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155222 · Cited by 1
“For example, in community-based cohort studies conducted in the United States and Europe, the lifetime risk of AF by the age of 80 is estimated to be around 24% for men and 22.5% for women [5].”
Influential
Subclinical atrial fibrillation: Implications of recent trials for guideline updates?
Pradhan, A. K., Shah, S., Vishwakarma, P., & Singh, A. K. (2026) · World Journal of Cardiology · doi:10.4330/wjc.v18.i1.111882 · Cited by 1
Association of atrial high-rate episodes daily burden with the risk of cardiovascular death, heart failure hospitalization, and stroke
Botto, G. L., Pisanò, E., Rapacciuolo, A., Lazzari, L., Bontempi, L., Pelargonio, G., Arena, G., Caccavo, V., Wang, C.-C., Merkley, B., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.02.048 · Cited by 1
Long PR Interval Leads to Atrial Remodeling, Fibrosis and Inducible Atrial Fibrillation in a Swine Model
Kataoka, S., Kwon, C. H., Lee, S. W., Venkateswaran, R. V., Stillson, C. A., Bibby, D., Schiller, N. B., Abraham, T. P., & Gerstenfeld, E. P. (2026) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2026.03.001 · Cited by 1
Women’s health initiative strong and healthy silent atrial fibrillation recording study: Rationale, study design, and baseline data
Gomez, S. E., Larson, J. C., Hlatky, M. A., Kooperberg, C. L., LaMonte, M. J., Tinker, L., Greenland, P., Albert, C. M., Froelicher, V. F., Wheeler, M. T., et al. (2026) · American Heart Journal · doi:10.1016/j.ahj.2026.107478 · Cited by 1

Authors: Glotzer, T. V., Hellkamp, A. S., Zimmerman, J., Sweeney, M. O., Yee, R., Marinchak, R., Cook, J., Paraschos, A., Love, J., Radoslovich, G., Lee, K. L., & Lamas, G. A.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Glotzer, Taya V.
Hellkamp, Anne S.
Zimmerman, John
Yee, Raymond
Lamas, Gervasio A.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2003-04
Volume: 107
Issue: 12
Pages: 1614-1619
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000057981.70380.45
OpenAlex: W2149989524
Cited by: 750
References: 28
Citations by year: 2026: 16 · 2025: 21 · 2024: 31 · 2023: 26 · 2022: 23 · 2021: 50 · 2020: 38 · 2019: 50 · 2018: 52 · 2017: 64 · 2016: 56 · 2015: 46 · 2014: 44 · 2013: 32 · 2012: 34
FWCI: 12.56
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: Medtronic
National Institutes of Health (5u01hl053973-05, 5u01hl055981-05)
National Heart, Lung, and Blood Institute (HL 53973, U01HL049804, U01 HL 53973, U01-HL-49804, U01-HL-55981)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: atrial high-rate episodes, atrial tachyarrhythmia, sick sinus syndrome, DDDR pacing, VVIR pacing, mode choice, atrial fibrillation, mortality, stroke, prognostic factors, asymptomatic arrhythmia
MeSH terms: Adult, Aged, Arrhythmias, Cardiac, Arrhythmia, Sinus, Atrial Fibrillation, Cardiac Pacing, Artificial, Female, Heart Atria, Humans, Male, Middle Aged, Electrocardiography, Ambulatory, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks